Generic Drug Reforms: FTC Notification Bill Appears Ready To Move In 2003
Executive Summary
A bill to require reporting of brand/generic patent settlements to the Federal Trade Commission appears ready to move early in the 108th Congress
You may also be interested in...
Senate Medicare Bill Directs GAO To Study International Price Controls
The Senate Medicare legislation would direct the General Accounting Office to produce a study of international price controls within one year of enactment
Senate Medicare Bill Directs GAO To Study International Price Controls
The Senate Medicare legislation would direct the General Accounting Office to produce a study of international price controls within one year of enactment
FDA Questions First-To-File Exclusivity As Generic Reforms Pass Senate
FDA has reservations about the current first-to-file basis for 180-day exclusivity, FDA Chief Counsel Daniel Troy acknowledged at a June 17 Senate Judiciary Committee hearing on generic drug reforms